Oncology Guide
Mucinous Adenocarcinoma (Colorectal)
Mucinous adenocarcinoma produces excess mucus. It tends to present at advanced stages and has worse prognosis than typical colorectal adenocarcinoma.
By Pulse Atlas Editorial
Updated
14 min read
Key Facts
- Prevalence: 10-15% of colorectal cancers
- Staging: TNM staging
- Screening: Colonoscopy
- Survival rate (5-year): 50% 5-year (worse than typical)
Symptoms of Mucinous Adenocarcinoma (Colorectal)
- As per colorectal cancer
Risk Factors
As per colorectal cancer
Risk factor
Young age at diagnosis
Risk factor
Diagnosis & Staging
Clinical evaluation
Discuss symptoms, medical history, and risk factors. Your doctor will perform a physical examination to assess for enlarged lymph nodes or other signs of mucinous adenocarcinoma (colorectal).
Imaging studies
CT scan, PET scan, or MRI to locate tumors, assess extent of disease, and identify metastatic spread.
Biopsy and pathology
Tissue biopsy confirms diagnosis and determines histologic subtype, grade, and genetic mutations (EGFR, ALK, HER2, etc.). Immunohistochemistry and molecular testing guide targeted therapy.
Staging
TNM staging (tumor size, node involvement, metastasis) or other staging systems determine disease extent and guide treatment planning.
Treatment planning
Multidisciplinary team recommends surgery, chemotherapy, radiation, targeted therapy, immunotherapy, or combinations based on stage, grade, patient fitness, and preferences.
Treatment Options
Aggressive Surgical Resection
With wider margins due to poorer prognosis
Depends on stage and patient factors
Recommended by oncology team
Multimodal Chemotherapy
Often more intensive regimens
Depends on stage and patient factors
Recommended by oncology team
Frequently Asked Questions
What is the difference between Mucinous Adenocarcinoma (Colorectal) and other cancer types? ▼
Mucinous Adenocarcinoma (Colorectal) develops in specific tissues and has distinct characteristics. Your pathology report will detail the specific type, stage, and genetic markers that determine optimal treatment.
How is staging determined? ▼
Staging uses TNM classification (Tumor size, Node involvement, Metastasis). Imaging studies, biopsy results, and sometimes blood tests determine the stage (0-IV). Stage guides treatment intensity and predicts prognosis.
Will I lose my hair? ▼
Hair loss depends on chemotherapy type. Some chemotherapies cause alopecia (reversible), while others don't. Your oncologist will discuss this before treatment starts.
What are clinical trials? ▼
Clinical trials test new treatments. Ask your oncology team if trials are appropriate for your disease stage and type. ClinicalTrials.gov lists ongoing UK trials.
⚠️ When to Seek Urgent Help
- Severe symptoms:
Seek urgent medical evaluation
- Difficulty breathing:
Call 999 or go to A&E
- Severe pain:
Contact your oncology team or A&E